New program aims to help refugee and underserved moms with depression and birth control

NCT ID NCT07659509

Not yet recruiting Disease control Sponsor: Eastern Mediterranean Public Health Network Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding mental health screening and family planning counseling to routine baby check-ups helps new mothers. About 920 migrant, refugee, and underserved women in Jordan will take part. They will be screened for postpartum depression, receive support or referrals, and get birth control advice. The goal is to see if this approach increases use of modern contraception and reduces depression symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Integrated mental health screening, psychosocial support, and family planning counseling
What this could lead to: If it works, this could provide a practical way to improve both mental health and contraceptive use for new mothers in underserved communities.
What could go wrong: This is a behavioral intervention study, not a drug trial, so results may vary by setting. It is early-stage and focuses on a specific population in Jordan, so findings may not apply elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FAMILY PLANNING SERVICES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

postpartum depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FAMILY PLANNING SERVICES POST PARTUM DEPRESSION

Contacts and locations

Locations

Alkhaldieh

Al Mafraq, 11181, Jordan
Alsheikh Hussein

Irbid, Amman Governorate, 11181, Jordan

More trials for these conditions

Other studies related to the condition(s) this trial covers.